Such oncogenic somatic alterations though vary across populations/ethnic groups, e.g. EGFR mutations are present in over 30% of East Asian lung adenocarcinoma patients, however, they are only found in ∼23%–25% of Indian and 10% of Western lung adenocarcinoma patients [6–8]. Here, EGFR is linked to lung adenocarcinoma.